OP 6.3 – 00150 Delivery and long-term expression of CCR5-blocking monoclonal antibody Leronlimab with AAV for ART-free remission from SHIV viremia

Journal article

Open access

Peer reviewed

G. Webb, H. Wu, C. Waytashek, C. Boyle, J. Smedley, J. Zikos, D. Magnani, S. Fuchs, R. Desrosiers and J. Sacha

Journal of Virus Eradication, Vol.8, p.100248

2022-12

Files and links (1)

url

https://doi.org/10.1016/j.jve.2022.100248View

Published (Version of record) Open

1 Record Views

Title: OP 6.3 – 00150 Delivery and long-term expression of CCR5-blocking monoclonal antibody Leronlimab with AAV for ART-free remission from SHIV viremia
Creators: G. Webb - Oregon Health And Science University, Beaverton, USA
H. Wu - Oregon Health And Science University, Beaverton, USA
C. Waytashek - Oregon Health And Science University, Beaverton, USA
C. Boyle - Oregon Health And Science University, Beaverton, USA
J. Smedley - Oregon National Primate Research Center
J. Zikos - Massbiologics, Boston, USA
D. Magnani - Massbiologics, Boston, USA
S. Fuchs - University of Miami
R. Desrosiers - University of Miami
J. Sacha - Oregon Health And Science University, Beaverton, USA
Publication Details: Journal of Virus Eradication, Vol.8, p.100248
Publisher: Elsevier Ltd
Academic Unit: Miller School of Medicine; UMMG Department of Pathology
Language: English
Resource Type: Journal article
Record Identifier: 991031786552302976